- Trials with a EudraCT protocol (9,800)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (2,720)
9,800 result(s) found for: System.
Displaying page 275 of 490.
EudraCT Number: 2016-000676-15 | Sponsor Protocol Number: GON_DHC_1 | Start Date*: 2016-05-31 | |||||||||||
Sponsor Name:Danish Headache Center | |||||||||||||
Full Title: GON-block in Chronic Migraine: a Randomized, Double- Blind, Placebo-controlled Study (DHC-GON-1) | |||||||||||||
Medical condition: Migraine (chronic) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-004495-12 | Sponsor Protocol Number: KCA2011/APAC | Start Date*: 2017-05-18 |
Sponsor Name:VU University Medical center | ||
Full Title: Antibiotic treatment alone for children with acute appendicitis; a prospective cohort study part of the Antibiotic versus Primary Appendectomy for Children with acute appendicitis; the APAC trial. | ||
Medical condition: Radiologically confirmed simple appendicitis, defined as: a. Clinical findings: Unwell, but not generally ill, Localized tenderness in the right iliac fossa region, Normal/hyperactive bowel sound... | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-019415-38 | Sponsor Protocol Number: CZOL446HDE38T | Start Date*: 2011-03-23 | |||||||||||
Sponsor Name:Universitätsklinikum Würzburg | |||||||||||||
Full Title: A prospective, bicentric, randomised, primarily double blind, placebo-controlled study to evaluate the efficacy of zoledronic acid for the treatment of bone marrow syndrome | |||||||||||||
Medical condition: Determination of efficacy of Zoledronic Acid on the treatment of bone marrow edema syndrome. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-000717-37 | Sponsor Protocol Number: AMGEVITA-HVM2019 | Start Date*: 2019-06-27 |
Sponsor Name:Fundación Publica Andaluza para la Gestión de Salud en Sevilla (FISEVI) | ||
Full Title: LOSS OF RESPONSE OF THE ADALIMUMAB BIOSIMILAR COMPARED WITH THE LOSS OF RESPONSE OF THE ADALIMUMAB ORIGINAL: CONTROLLED, RANDOMIZED, NON-INFERIORITY OPEN STUDY. "ADA-SWITCH Study" | ||
Medical condition: Inflammatory Bowel Disease: Crohn's Disease and Ulcerative Colitis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2008-006704-27 | Sponsor Protocol Number: Bezafibrate | Start Date*: 2009-07-17 | |||||||||||
Sponsor Name:Neuromuscular Research Unit, Copenhagen University Hospital Rigshopspitalet | |||||||||||||
Full Title: Effect of Bezafibrate on muscle metabolism during exercise in patients with fat metabolic disorders in skeletal muscle | |||||||||||||
Medical condition: Evaluation of the effect of Bezafibrate on muscle metabolism during exercise in patients with VLCAD and CPT II deficiency | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-000320-18 | Sponsor Protocol Number: FASE01 | Start Date*: 2012-11-22 | ||||||||||||||||
Sponsor Name:Parnassia Bavo Groep - PsyQ | ||||||||||||||||||
Full Title: Phase shift in adult ADHD of sleep and apetite. | ||||||||||||||||||
Medical condition: Delayed Sleep Phase Syndrome (DSPS) in adult patients with Attention-Deficit/Hyperctivity Disorder (ADHD) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-000459-10 | Sponsor Protocol Number: PADIT | Start Date*: 2014-06-10 | |||||||||||
Sponsor Name:Population Health Research Institute (PHRI) | |||||||||||||
Full Title: A cluster Crossover Trial Comparing Conventionl vs Incremental Antibiotic Therapy for the Prevention or Arrhytmia Device Infection | |||||||||||||
Medical condition: high-risk patients undergoing arrhythmia device procedures | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-013930-25 | Sponsor Protocol Number: 2009-600 | Start Date*: 2009-11-24 | |||||||||||
Sponsor Name:Aarhus University Hospital, Department of Neurology | |||||||||||||
Full Title: Randomiseret, dobbelt blindet placebokontrolleret undersøgelse af subkutan immunglobulinbehandling af kronisk inflammatorisk demyeliniserende polyradikuloneuropati (English: A randomized, double-... | |||||||||||||
Medical condition: Chronic inflammatory demyelinating polyradiculoneuropathy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-004244-33 | Sponsor Protocol Number: ATYR1923-C-002 | Start Date*: 2019-10-21 | |||||||||||
Sponsor Name:aTyr Pharma, Inc. | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled Multiple Ascending Dose Study of Intravenous ATYR1923 in Patients with Pulmonary Sarcoidosis | |||||||||||||
Medical condition: Pulmonary Sarcoidosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-002140-88 | Sponsor Protocol Number: CL04-ORY-2001 | Start Date*: 2018-09-06 | |||||||||||
Sponsor Name:Oryzon Genomics S.A. | |||||||||||||
Full Title: An unicenter, open-label, 1-arm, 8-week study to evaluate the efficacy, safety and tolerability of ORY-2001 in aggression in adult population with Alzheimer’s Disease (AD), Lewy Body Dementia (LBD)... | |||||||||||||
Medical condition: Agression | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-001910-88 | Sponsor Protocol Number: ATYR1940-C-004 | Start Date*: 2015-12-17 | |||||||||||
Sponsor Name:aTyr Pharma, Inc. | |||||||||||||
Full Title: An Open-Label, Intrapatient Dose Escalation Study to Evaluate the Safety, Tolerability, Immunogenicity, and Biological Activity of ATYR1940 in Patients with Limb Girdle and Facioscapulohumeral Musc... | |||||||||||||
Medical condition: Limb Girdle Muscular Dystrophy and Facioscapulohumeral Muscular Dystrophy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-001364-19 | Sponsor Protocol Number: BO29563 | Start Date*: 2015-12-15 | |||||||||||||||||||||
Sponsor Name:F. HOFFMANN - LA ROCHE LTD. | |||||||||||||||||||||||
Full Title: A phase Ib/II study evaluating the safety and efficacy of MPDL3280A in combination with either obinutuzumab plus bendamustine or obinutuzumab plus CHOP in patients with follicular lymphoma or diffu... | |||||||||||||||||||||||
Medical condition: Follicular lymphoma or diffuse large B-cell lymphoma | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: IT (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2017-004601-40 | Sponsor Protocol Number: MR311-3505 | Start Date*: 2018-11-22 | |||||||||||
Sponsor Name:MUNDIPHARMA RESEARCH LIMITED | |||||||||||||
Full Title: Efficacy and safety of methoxyflurane in helicopter emergency medical system and hostile environment: a prospective, multicentre clinical trial | |||||||||||||
Medical condition: moderate to severe pain secondary to minor trauma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-000160-28 | Sponsor Protocol Number: SMA-002 | Start Date*: 2018-11-06 | |||||||||||
Sponsor Name:CATALYST PHARMACEUTICALS INC. | |||||||||||||
Full Title: Long term safety study of amifampridine phosphate in ambulatory patients with Spinal Muscular Atrophy (SMA) type 3 | |||||||||||||
Medical condition: Spinal Muscular Atrophy (SMA) Type 3 | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-004140-38 | Sponsor Protocol Number: P160923J | Start Date*: 2018-12-14 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: A phase II study from the POLA national network of nivolumab for recurrent IDH mutated High-Grade Gliomas | |||||||||||||
Medical condition: Adults with recurrent IDH mutated high grade gliomas (IDHm HGGs) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-000375-16 | Sponsor Protocol Number: BUS-P2-01 | Start Date*: 2019-06-14 | |||||||||||
Sponsor Name:Bellus Health Inc. | |||||||||||||
Full Title: A Randomized, Double-blind, Placebo-Controlled, Crossover, Dose Escalation Study of BLU-5937 in Subjects with Unexplained or Refractory Chronic Cough | |||||||||||||
Medical condition: Unexplained or Refractory Chronic Cough | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-004070-42 | Sponsor Protocol Number: A4250PBCpruritus | Start Date*: 2014-12-09 |
Sponsor Name:Sahlgrenska Academy | ||
Full Title: An Exploratory, Phase IIa Cross-Over Study to Demonstrate the Efficacy and Safety of A4250 in Patients with Primary Biliary Cirrhosis and Cholestatic Pruritus | ||
Medical condition: Primary biliary cirrhosis complicated by cholestatic pruritus. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2012-003641-15 | Sponsor Protocol Number: 2625 | Start Date*: 2013-07-04 |
Sponsor Name:North Bristol NHS Trust | ||
Full Title: Reducing pathology in Alzheimer’s Disease through Angiotensin taRgeting. The RADAR Trial. A phase II, two arm, double-blind, placebo-controlled, randomised trial to evaluate the effect of losartan ... | ||
Medical condition: Alzheimer's Disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-001418-14 | Sponsor Protocol Number: VELOCE | Start Date*: 2019-07-11 | |||||||||||
Sponsor Name:UMBERTO I - POLICLINICO DI ROMA | |||||||||||||
Full Title: Assessment of clinical efficacy of Sildenafil 75 mg orodispersable film vs Sildenafil 100 mg tablet in patients with erectile dysfunction | |||||||||||||
Medical condition: Erectile Dysfunction | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-000730-19 | Sponsor Protocol Number: HEEL-2011-02 | Start Date*: 2012-08-23 | |||||||||||
Sponsor Name:Radboud University Nijmegen Medical Centre | |||||||||||||
Full Title: The analgesic efficacy of Δ9-THC (Namisol®) in Chronic Pancreatitis Patients Suffering From Persistent Abdominal Pain: a Randomized, Double-blinded, Placebo-controlled, Parallel Design | |||||||||||||
Medical condition: Chronic pancreatitis with persistant abdominal pain | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Prematurely Ended) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
